Ledger.Open graph →
SEC Form D · filed April 9, 2020

iTeos Therapeutics, Inc

Offering
$125.4M
Sold
$125.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Priyanka Belawat · Cambridge, MADirectorDavid Hallal · New Brighton, MNDirectorDetlev Biniszkiewicz · Cambridge, MADirectorMichel Detheux · Cambridge, MAExec · DirectorAnsbert Gadicke · CAMBRIDGE, MADirectorTim Van Hauwermeiren · Cambridge, MADirectorChris Buyse · Cambridge, MADirectorJonathan Skipper · Cambridge, MADirectorDavid Hallal · New Brighton, MNDirectorDetlev Biniszkiewicz · Cambridge, MADirectorMichel Detheux · Cambridge, MAExec · DirectorPriyanka Belawat · Cambridge, MADirectorAnsbert Gadicke · New Brighton, MNDirectorTim Van Hauwermeiren · Cambridge, MADirectorChris Buyse · Cambridge, MADirectorJonathan Skipper · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗